Actively Recruiting
Tunisian Lung Cancer Study
Led by Dacima Consulting · Updated on 2025-06-04
1334
Participants Needed
2
Research Sites
78 weeks
Total Duration
On this page
Sponsors
D
Dacima Consulting
Lead Sponsor
T
The Multidisciplinary Consultation Meeting Thoracic Oncology of the Abderrahmen Mami Hospital (ROTHAM)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.
CONDITIONS
Official Title
Tunisian Lung Cancer Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age more than 18 years
- Patients receiving health care in pulmonology, oncology, radiation oncology, or thoracic surgery departments with lung cancer diagnosis confirmed histologically and/or by cytology at least 3 months before inclusion
- Provided informed consent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Tunisian Society of Medical Oncology
Aryanah, Tunisia, 2080
Not Yet Recruiting
2
Tunisian Society of Respiratory Diseases and Allergology
Tunis, Tunisia
Actively Recruiting
Research Team
S
Soraya Fenniche, MD
CONTACT
N
Nesrine Mejri, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here